Nomura Securities Maintains a 'Buy' on Shire plc (SHPGY); FDA Approved Generic Version of Adderall-XR
Tweet Send to a FriendGet Alerts SHPGY Hot Sheet
Price: $85.67 -0.2%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 16
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 16
Trade SHPGY Now!
Nomura Securities maintains a 'Buy' on Shire plc (NASDAQ: SHPGY).
Analyst, Bhuna Signhal, said, "The FDA has approved a generic version of Adderall-XR (10% of EPS). The EMA has rejected Pfizer’s Taliglucerase, a potential competitor to Shire’s Vpriv (10% of EPS). We had previously flagged that (given the FDA’s recent approval of a generic version of another ADHD drug) Adderall-XR will go generic and had removed the drug from our model. Therefore, the FDA news makes little change to our 11% EPS CAGR forecast for Shire. We do, however, make changes to reflect possible earlier onset of sales erosion than previously anticipated and lower 2012-14E EPS by 3-8%."
For an analyst ratings summary and ratings history on Shire plc click here. For more ratings news on Shire plc click here.
Shares of Shire plc closed at $91.36 yesterday, with a 52 week range of $82.11-$108.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Bhuna Signhal, said, "The FDA has approved a generic version of Adderall-XR (10% of EPS). The EMA has rejected Pfizer’s Taliglucerase, a potential competitor to Shire’s Vpriv (10% of EPS). We had previously flagged that (given the FDA’s recent approval of a generic version of another ADHD drug) Adderall-XR will go generic and had removed the drug from our model. Therefore, the FDA news makes little change to our 11% EPS CAGR forecast for Shire. We do, however, make changes to reflect possible earlier onset of sales erosion than previously anticipated and lower 2012-14E EPS by 3-8%."
For an analyst ratings summary and ratings history on Shire plc click here. For more ratings news on Shire plc click here.
Shares of Shire plc closed at $91.36 yesterday, with a 52 week range of $82.11-$108.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Jefferies Boosts PT on Micron (MU) Post Q3; Sees 50% Upside
- Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, FDARelated Entities
Nomura
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
